Prophylactic Therapy With Valgancyclovir in High-Risk (Cytomegalovirus D+/R−) Liver Transplant Recipients: A Single-Center Experience
M. Montejo, E. Montejo, M. Gastaca, A. Valdivieso, J.R. Fernandez, M. Testillano, J. Gonzalez, J. Bustamante, P. Ruiz, M.J. Suarez, A. Ventoso, M.C. Rubio, J. Ortiz de UrbinaVolume:
41
Year:
2009
Language:
english
DOI:
10.1016/j.transproceed.2009.06.005
File:
PDF, 98 KB
english, 2009